ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press

April 10, 1987

Adriamycin Fact Sheet Available

July 4, 1975

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008